How Labeling Warnings and Precautions May Impact the Proportion of Psoriasis Patients Initiating New Treatments

Main Article Content

Richard Langley
Shauna Jardon
Jennifer Montgomery
Kate K. Orroth
Cynthia Deignan
Mark Lebwohl
Dawn Nicewarner


Safety, moderate to severe plaque psoriasis, systemic, biologic


1. Wallace BI, et al. Prevalence of immunosuppressive drug use among commercially insured US adults, 2018-2019. JAMA Network Open. 2021;4(5):e214920.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>